All Releases
 |
Questcor to Participate in Upcoming Conferences
Jul 29, 2010
|
6.5 KB |
|
| |
UNION CITY, Calif., July 29, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will participate in the following upcoming investor conferences:
The BMO Capital Markets 10th Annual Focus on Healthcare Conference
Thursday, August 5, 2010
New York, NY
4:00 p.m. ET...
|
|
Questcor Reports Second Quarter 2010 Results
Jul 28, 2010
|
28.1 KB |
|
| |
UNION CITY, Calif., July 28, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported financial results for the second quarter ended June 30, 2010. The Company's financial performance was driven primarily by a 145% year-over-year increase in the number of new paid Acthar prescriptions for the treatm...
|
|
Questcor Announces Second Quarter 2010 Earnings Release Date and Conference Call
Jul 15, 2010
|
7.4 KB |
|
| |
UNION CITY, Calif., July 15, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will release financial results for the second quarter ended June 30, 2010 on Wednesday, July 28, 2010 after the market close. The Company will host a conference call and webcast on Wednesday, July 28, 2010...
|
|
Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
Jul 6, 2010
|
11.0 KB |
|
| |
UNION CITY, Calif., July 6, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that Mitchell J. Blutt, M.D. has been appointed to its Board of Directors. Dr. Blutt, 53, is the Founder and Chief Executive Officer of Consonance Capital, a New York City-based investment firm that is a shareholde...
|
|
Questcor Receives Notification of PDUFA Date Extension to September 11, 2010
Jun 11, 2010
|
6.6 KB |
|
| |
UNION CITY, Calif., June 11, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it has received notification from the U.S. Food & Drug Administration (FDA) that the PDUFA date for Questcor's supplemental new drug application (sNDA) to approve Acthar for the treatment of infantile spasms (...
|
|
Questcor to Present at the Jefferies 2010 Global Life Sciences Conference
Jun 2, 2010
|
6.9 KB |
|
| |
UNION CITY, Calif., June 2, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will present at the Jefferies 2010 Global Life Sciences Conference on Thursday, June 10, 2010 at The Grand Hyatt Hotel in New York, New York. Don M. Bailey, President and Chief Executive Officer, will discu...
|
|
Trading Halted Today in Questcor Pharmaceuticals Common Stock
May 6, 2010
|
7.6 KB |
|
| |
UNION CITY, Calif., May 6, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that NASDAQ has halted trading of Questcor's common stock pending news. The Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) meets today to review and disc...
|
|
Questcor to Discuss Results From FDA Panel Meeting
May 3, 2010
|
7.4 KB |
|
| |
UNION CITY, Calif., May 3, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will host a conference call and webcast to discuss the results of the FDA Panel meeting on Monday, May 10, 2010 at 4:30 p.m. Eastern / 1:30 p.m. Pacific. Don Bailey, President and Chief Executive Officer; St...
|
|
Questcor Reports First Quarter 2010 Results
Apr 29, 2010
|
27.6 KB |
|
| |
UNION CITY, Calif., April 29, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported improved year-over-year financial results for the first quarter ended March 31, 2010. The Company's financial performance was driven primarily by:
a 197% increase in the number of new paid Acthar prescriptions fo...
|
|
Questcor Announces First Quarter 2010 Earnings Release Date and Conference Call
Apr 15, 2010
|
7.3 KB |
|
| |
UNION CITY, Calif., April 15, 2010 /PRNewswire via COMTEX News Network/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will release financial results for the first quarter ended March 31, 2010 on Thursday, April 29, 2010 after the market close. The Company will host a conference call and webcast on Thursday, April 29, 20...
|
|
Questcor Reports Solid Fourth Quarter Results
Mar 1, 2010
|
5.1 KB |
|
| |
http://finance.yahoo.com/news/Questcor-Reports-Solid-Fourth-prnews-1906025805.html?x=0
...
|
|
Questcor Announces Fourth Quarter 2009 Earnings Release Date and Conference Call
Feb 11, 2010
|
6.5 KB |
|
| |
UNION CITY, Calif., Feb. 11, 2010 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the fourth quarter ended December 31, 2009 on Monday, March 1, 2010 after the market close. The Company will host a conference call and webcast on Monday, March 1, 2010 at 5:00 p.m. Eastern / ...
|
|
Questcor Appoints Jason Zielonka, M.D. Chief Medical Officer
Feb 4, 2010
|
14.9 KB |
|
| |
UNION CITY, Calif., Feb. 4, 2010 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that Jason Zielonka, M.D., (61), has been appointed to the position of Chief Medical Officer. Dr. Zielonka has accepted the Company's offer to become Chief Medical Officer effective February 16, 2010 and will report directly to Don M. ...
|
|
FDA Accepts for Review Questcor's Filing of Its Supplemental New Drug Application for H.P. Acthar® Gel for Treatment of Infantile Spasms
Dec 24, 2009
|
11.0 KB |
|
| |
UNION CITY, Calif., Dec. 24, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced the U.S. Food & Drug Administration (FDA) now considers that Questcor has provided a complete response to all prior action letters for its supplemental New Drug Application (sNDA) to market H.P. Acthar®...
|
|
Louis Silverman Appointed to Questcor Board of Directors
Dec 11, 2009
|
11.3 KB |
|
| |
UNION CITY, Calif., Dec. 11, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that Louis E. Silverman has been appointed to its Board of Directors. Mr. Silverman, 51 is currently Chief Executive Officer of privately-held Marina Medical Billing Service Inc. based in Cerritos, CA, , a company focused on providing ...
|
|
Questcor Announces Third Quarter 2009 Results
Nov 2, 2009
|
28.8 KB |
|
| |
UNION CITY, Calif., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today reported financial results for its third quarter ended September 30, 2009. As previously reported on September 21, 2009, Questcor's financial results w...
|
|
Questcor to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
Oct 27, 2009
|
7.7 KB |
|
| |
UNION CITY, Calif., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that it will present at the 20th Annual Oppenheimer Healthcare Conference on Wednesday, November 4, 2009 at The Waldorf-Astoria Hotel ...
|
|
Questcor Issues Corrected Dial-in Numbers for November 2nd Quarterly Conference Call
Oct 26, 2009
|
8.2 KB |
|
| |
UNION CITY, Calif., Oct. 26, 2009 (GLOBE NEWSWIRE) -- In the news release, "Questcor Announces Third Quarter 2009 Earnings Release Date and Conference Call," issued on October 23, 2009 by Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR), the conference call dial-in numbers ...
|
|
Questcor Announces Third Quarter 2009 Earnings Release Date and Conference Call
Oct 23, 2009
|
8.0 KB |
|
| |
UNION CITY, Calif., Oct. 23, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the third quarter ended September 30, 2009 on Monday, November 2, 2009 after the market close. Th...
|
|
Questcor Implements Two Corporate Governance Actions
Oct 22, 2009
|
7.9 KB |
|
| |
UNION CITY, Calif., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that its Board of Directors has unanimously approved two corporate governance matters to provide Questcor's shareholders more say with respect to proposals to acquire the...
|
|
|
